We report about a thirty-five-year-old male patient with miliary TB as first manifestation of HIV-infection. Zusammenfassung ! Wir berichten über einen 35-jährigen Patienten mit Miliartuberkulose als Erstmanifestation einer HIV-Infektion.
The Case ! A thirty-five-year-old black male patient (BMI 21.1 kg/m 2 ) was transferred to our hospital for further treatment of miliary tuberculosis (TB) which had been diagnosed elsewhere. Besides hepatomegalia due to confirmed tuberculotic affection, a CT scan showed enlarged mediastinal and abdominal lymph nodes with features of central necrosis and multiple disseminated pulmonary and splenic lesions (• " Fig. 1 -3 ). HIV testing was positive, most likely as a consequence of unsafe sexual contacts with changing partners during a long-term stay in his home-country Kenya. Therefore, due to 1) HIV infection, 2) tuberculosis as acquired immune deficiency syndrome (AIDS)defining disease and 3) a CD4-cell count of 30 per µl AIDS in CDC category C3 was diagnosed [1] . Standard antituberculotic treatment consisting of isoniazide (H), rifampicine (R), ethambutole (E) and pyrazinamide (Z) [2] had been paused at the time of admission to our hospital due to elevation of liver enzymes. Consequently, first sputum samples obtained in our hospital showed smearpositive pulmonary TB. Later on, the cultural result showed Mycobacterium tuberculosis (MTB) multisensitive to the antituberculotic medication mentioned above. We restarted treatment with E and replaced R, Z and H by levofloxacin (LFX), streptomycin (SM) and rifabutin (RFB). As to lymph node enlargement, lymphoma as well as Pneumocystis jiroveci (PCJ)-pneumonia as additional AIDS-defining diseases was excluded. Meanwhile, bone marrow samples indicated additional TB-affection (• " Fig. 4 ). Under treatment with SM for 30 days, LFX, RFB and E sputum samples were negative for MTB. Blood samples showed rising CD4-cell count and 1 734 015 copies of HIV-1 per ml. After patient's transfer to a specialized department for AIDS, antituberculotic medication could be switched to RFB, E, Z and H with sustained success concerning microbiological results and stable laboratory liver parameters. Antiretroviral treatment with efavirenz, emtricitabine, and tenofovir was initiated. After four months of therapy, antituberculotic treatment could be reduced to RFB and H. Before admission to our hospital electrolyte imbalance with severe hyponatremia had been observed. Retrospectively, they were most likely due to syndrome of inadequate antidiuretic hormone secretion (SIADH) as TB-related phenomenon [3] . However, this assumption could not be verified, since levels of electrolytes and Copeptin A, a new biomarker for SIADH [4] , were normalized at time of admission to our department. Copeptin has been evaluated as prognostic biomarker in community acquired-pneumonia [5, 6] , but its diagnostic value in SIADH in the context of infectious diseases might be limited to a narrow time slot. 
